Aims We report our experience with three generations of the Cardia patent foramen ovale
(PFO) occluder in patients with cryptogenic thrombo-embolic events (TE). Methods and …

Patent foramen ovale (PFO) is a normal fetal communication between the right and left atria
that persists after birth. PFO is a common finding that occurs in 20–34% of the population …

Objective: To compare the safety and efficacy of percutaneous closure of patent foramen
ovale (PFO) with the Amplatzer PFO occluder (Amplatzer) or the PFO STAR device (STAR) …

This article has been corrected. The original version (PDF) is appended to this article as a
Supplement. Background: The optimal strategy for preventing recurrent stroke in patients …

Patent foramen ovale (PFO) is a common benign finding in healthy subjects, but its
prevalence is higher in patients with stroke of unclear cause (cryptogenic stroke). PFO is …

Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The
dilemma of whether to close these PFOs percutaneously, in an effort to reduce the risk of …

Objective: To update the 2004 American Academy of Neurology guideline for patients with
stroke and patent foramen ovale (PFO) by addressing whether (1) percutaneous closure of …

Background and Purpose—Transcatheter closure of patent foramen ovale (PFO) is
increasingly being performed and monitored with transthoracic or transesophageal …

Objectives: This study sought to identify predictors of recurrent ischemic neurologic events
within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a …

Aims: We aimed at updating the evidence coming from randomised and observational
studies of patent foramen ovale (PFO) closure compared to medical therapy in patients with …